{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:22:58Z","timestamp":1782894178110,"version":"3.54.5"},"reference-count":119,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Phenothiazine and its N-substituted derivatives are pivotal in heterocyclic chemistry, and\nserves as potential building blocks in chemical and pharmaceutical sciences. Over the past decade,\nextensive research has focused on the medicinal potentials of these compounds, exploring their anticancer,\nanalgesic, anti-tumor, anti-inflammatory, and antibacterial properties. Due to their distinctive\nchemical compositions, phenothiazine and its N-substituted derivatives have facilitated the development\nof novel substitutions. This paper reviews recent advancements in the synthesis of phenothiazine\nand its N-substituted derivatives, with an emphasis on their potential biological roles.\nNumerous investigations have identified various types of phenothiazine and its N-substituted derivatives\nthat exhibit compelling biological characteristics. It discusses the impact of different functional\ngroups on phenothiazine at the N-substitution, specifically Cl, CF\u2083, OH, N(C\u2082H\u2085)\u2082, and (CH\u2082)\u2085CH\u2083.\nFurthermore, the relationship between the biological activities and the structural characteristics of\nthe compounds is examined, identifying the chemical groups and structural alterations that enhance\nbioactivity, reduce toxicity, and improve handling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575400761251007165058","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:09:51Z","timestamp":1761894591000},"page":"467-496","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Analysis of the Therapeutic Potential of N-substituted Phenothiazine Derivatives in Medicinal Chemistry"],"prefix":"10.2174","volume":"26","author":[{"given":"Deepanjali","family":"Shukla","sequence":"first","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Azad","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Arsh","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahat Yasmeen","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal Akhtar","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahman","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3675-9997","authenticated-orcid":true,"given":"Firoj","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Integral University, Lucknow, 226026, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2174\/138945006778226552","volume":"7","author":"Mitchell S.","year":"2006","unstructured":"Mitchell S.; Phenothiazine: The parent molecule. Curr Drug Targets  2006,7(9),1181-1189","journal-title":"Curr Drug Targets"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.ejmech.2011.05.013","volume":"46","author":"Pluta K.","year":"2011","unstructured":"Pluta K.; Morak-M\u0142odawska B.; Jele\u0144 M.; Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem  2011,46(8),3179-3189","journal-title":"Eur J Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","volume":"16","author":"Ohlow M.J.","year":"2011","unstructured":"Ohlow M.J.; Moosmann B.; Phenothiazine: The seven lives of pharmacology\u2019s first lead structure. Drug Discov Today  2011,16(3-4),119-131","journal-title":"Drug Discov Today"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/cr60171a003","volume":"54","author":"Massie S.P.","year":"1954","unstructured":"Massie S.P.; The chemistry of phenothiazine. Chem Rev  1954,54(5),797-833","journal-title":"Chem Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","volume":"64","author":"Jaszczyszyn A.","year":"2012","unstructured":"Jaszczyszyn A.; G\u0105siorowski K.; \u015awi\u0105tek P.; Malinka W.; Cie\u015blik-Boczula K.; Petrus J.; Czarnik-Matusewicz B.; Chemical structure of phenothiazines and their biological activity. Pharmacol Rep  2012,64(1),16-23","journal-title":"Pharmacol Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1039\/9781782622246-00231","author":"Martinez A.","year":"2015","unstructured":"Martinez A.; Gil C.; Heterocycles containing nitrogen and sulfur as potent biologically active scaffolds. Drug Disc  2015(50),231-261","journal-title":"Drug Disc"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1039\/c8pp00584b","volume":"18","author":"Vara J.","year":"2019","unstructured":"Vara J.; Gualdesi M.S.; Aiassa V.; Ortiz C.S.; Evaluation of physicochemical properties and bacterial photoinactivation of phenothiazine photosensitizers. Photochem Photobiol Sci  2019,18(6),1576-1586","journal-title":"Photochem Photobiol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12088-024-01309-3","volume":"64","author":"Ronco T.","year":"2024","unstructured":"Ronco T.; Juul M.; Reynier Z.; Christensen J.B.; Svenningsen S.; Olsen R.H.; Phenothiazine derivatives: The importance of stereoisomerism in the tolerance and efficacy of antimicrobials. Indian J Microbiol  2024,64(2),743-748","journal-title":"Indian J Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"Balouiri M.","year":"2016","unstructured":"Balouiri M.; Sadiki M.; Ibnsouda S.K.; Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal  2016,6(2),71-79","journal-title":"J Pharm Anal"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1192\/bjp.120.554.41","volume":"120","author":"Hershon H.I.","year":"1972","unstructured":"Hershon H.I.; Kennedy P.F.; Mcguire R.J.; Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. Br J Psychiatry  1972,120(554),41-50","journal-title":"Br J Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.2174\/0929867328666210405120330","volume":"28","author":"Gonz\u00e1lez-Gonz\u00e1lez A.","year":"2021","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez A.; Vazquez-Jimenez L.K.; Paz-Gonz\u00e1lez A.D.; Bolognesi M.L.; Rivera G.; Recent advances in the medicinal chemistry of phenothiazines, new anticancer and antiprotozoal agents. Curr Med Chem  2021,28(38),7910-7936","journal-title":"Curr Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11030-023-10619-5","volume":"28","author":"Sadhu C.","year":"2024","unstructured":"Sadhu C.; Mitra A.K.; Synthetic, biological and optoelectronic properties of phenoxazine and its derivatives: A state of the art review. Mol Divers  2024,28(2),965-1007","journal-title":"Mol Divers"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/17460441.2020.1816962","volume":"16","author":"St\u0119pnicki P.","year":"2021","unstructured":"St\u0119pnicki P.; Kondej M.; Kosz\u0142a O.; \u017buk J.; Kaczor A.A.; Multi-targeted drug design strategies for the treatment of schizophrenia. Expert Opin Drug Discov  2021,16(1),101-114","journal-title":"Expert Opin Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.mjt.0000212897.20458.63","volume":"13","author":"Mosnaim A.D.","year":"2006","unstructured":"Mosnaim A.D.; Ranade V.V.; Wolf M.E.; Puente J.; Antonieta Valenzuela M.; Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. Am J Ther  2006,13(3),261-273","journal-title":"Am J Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"30594","DOI":"10.1021\/acsomega.3c06532","volume":"9","author":"Kisla M.M.","year":"2024","unstructured":"Kisla M.M.; Yaman M.; Zengin-Karadayi F.; Korkmaz B.; Bayazeid O.; Kumar A.; Peravali R.; Gunes D.; Tiryaki R.S.; Gelinci E.; Cakan-Akdogan G.; Ates-Alagoz Z.; Konu O.; Synthesis and structure of novel phenothiazine derivatives, and compound prioritization via in silico target search and screening for cytotoxic and cholinesterase modulatory activities in liver cancer cells and in vivo in Zebrafish. ACS Omega  2024,9(28),30594-30614","journal-title":"ACS Omega"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1021\/acs.joc.5b00568","volume":"80","author":"Hu W.","year":"2015","unstructured":"Hu W.; Zhang S.; Method for the synthesis of phenothiazines via a domino iron-catalyzed C\u2013S\/C\u2013N cross-coupling reaction. J Org Chem  2015,80(12),6128-6132","journal-title":"J Org Chem"},{"key":"ref=17","first-page":"786","volume":"4","author":"Naik N.","year":"2012","unstructured":"Naik N.; Kumar H.V.; Veena V.; Novel phenothiazine analogous: Synthesis and a new perceptivity into their antioxidant potential. Pharm Lett  2012,4(3),786-794","journal-title":"Pharm Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1021\/acs.joc.4c00039","volume":"89","author":"Zhao Y.","year":"2024","unstructured":"Zhao Y.; Zhang J.; Zhang J.; Zhang Z.; Liu R.; Iodine-catalyzed cyclization of o-nitrothiophenols with cyclohexanones to phenothiazines. J Org Chem  2024,89(11),7478-7484","journal-title":"J Org Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1039\/c2cc30814b","volume":"48","author":"Dai C.","year":"2012","unstructured":"Dai C.; Sun X.; Tu X.; Wu L.; Zhan D.; Zeng Q.; Synthesis of phenothiazines via ligand-free CuI-catalyzed cascade C\u2013S and C\u2013N coupling of aryl ortho-dihalides and ortho-aminobenzenethiols. Chem Commun  2012,48(43),5367-5369","journal-title":"Chem Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.bmcl.2007.03.064","volume":"17","author":"Madrid P.B.","year":"2007","unstructured":"Madrid P.B.; Polgar W.E.; Toll L.; Tanga M.J.; Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors. Bioorg Med Chem Lett  2007,17(11),3014-3017","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1002\/ejoc.201500667","volume":"2015","author":"Huang M.","year":"2015","unstructured":"Huang M.; Huang D.; Zhu X.; Wan Y.; Copper\u2010catalyzed domino reactions for the synthesis of phenothiazines. Eur J Org Chem  2015,2015(22),4835-4839","journal-title":"Eur J Org Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"18605","DOI":"10.1039\/c3ra43989e","volume":"3","author":"Liao Y.","year":"2013","unstructured":"Liao Y.; Jiang P.; Chen S.; Xiao F.; Deng G.J.; Synthesis of phenothiazines from cyclohexanones and 2-aminobenzenethiols under transition-metal-free conditions. RSC Advances  2013,3(40),18605-18608","journal-title":"RSC Advances"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"24257","DOI":"10.1039\/C6RA01295G","volume":"6","author":"Wu S.","year":"2016","unstructured":"Wu S.; Hu W.Y.; Zhang S.L.; Potassium carbonate-mediated tandem C\u2013S and C\u2013N coupling reaction for the synthesis of phenothiazines under transition-metal-free and ligand-free conditions. RSC Advances  2016,6(29),24257-24260","journal-title":"RSC Advances"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1021\/acs.joc.1c00403","volume":"86","author":"Rui X.","year":"2021","unstructured":"Rui X.; Wang C.; Si D.; Hui X.; Li K.; Wen H.; Li W.; Liu J.; One-pot tandem access to phenothiazine derivatives from acetanilide and 2-bromothiophenol via rhodium-catalyzed C\u2013H thiolation and copper-catalyzed C\u2013N amination. J Org Chem  2021,86(9),6622-6632","journal-title":"J Org Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1021\/acs.orglett.5b03058","volume":"17","author":"Chen J.","year":"2015","unstructured":"Chen J.; Li G.; Xie Y.; Liao Y.; Xiao F.; Deng G.J.; Four-component approach to N -substituted phenothiazines under transition-metal-free conditions. Org Lett  2015,17(23),5870-5873","journal-title":"Org Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/00397911.2017.1281959","volume":"47","author":"Zhou Y.","year":"2017","unstructured":"Zhou Y.; Zeng Q.; Zhang L.; Transition-metal-free synthesis of phenothiazines from S-2-acetamidophenyl ethanethioate and ortho -dihaloarenes. Synth Commun  2017,47(7),710-715","journal-title":"Synth Commun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","volume":"25","author":"Omoruyi S.I.","year":"2020","unstructured":"Omoruyi S.I.; Ekpo O.E.; Semenya D.M.; Jardine A.; Prince S.; Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. Apoptosis  2020,25(3-4),261-274","journal-title":"Apoptosis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"106924","DOI":"10.1016\/j.bioorg.2023.106924","volume":"141","author":"Sarhan M.O.","year":"2023","unstructured":"Sarhan M.O.; Haffez H.; Elsayed N.A.; El-Haggar R.S.; Zaghary W.A.; New phenothiazine conjugates as apoptosis inducing agents: Design, synthesis, in-vitro anti-cancer screening and 131I-radiolabeling for in-vivo evaluation. Bioorg Chem  2023,141,106924","journal-title":"Bioorg Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.molliq.2019.04.102","volume":"285","author":"Slodek A.","year":"2019","unstructured":"Slodek A.; Zych D.; Maro\u0144 A.; Gawecki R.; Mrozek-Wilczkiewicz A.; Malarz K.; Musio\u0142 R.; Phenothiazine derivatives -Synthesis, characterization, and theoretical studies with an emphasis on the solvatochromic properties. J Mol Liq  2019,285,515-525","journal-title":"J Mol Liq"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/molecules24020267","volume":"24","author":"Morak-M\u0142odawska B.","year":"2019","unstructured":"Morak-M\u0142odawska B.; Pluta K.; Latocha M.; Jele\u0144 M.; Ku\u015bmierz D.; Synthesis, anticancer activity, and apoptosis induction of novel 3,6-diazaphenothiazines. Molecules  2019,24(2),267","journal-title":"Molecules"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"127037","DOI":"10.1016\/j.molstruc.2019.127037","volume":"1199","author":"Krishnan K.G.","year":"2020","unstructured":"Krishnan K.G.; Kumar C.U.; Lim W.M.; Mai C.W.; Thanikachalam P.V.; Ramalingan C.; Novel cyanoacetamide integrated phenothiazines: Synthesis, characterization, computational studies and in vitro antioxidant and anticancer evaluations. J Mol Struct  2020,1199,127037","journal-title":"J Mol Struct"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1570180816666181115112236","volume":"17","author":"Luan Y.","year":"2019","unstructured":"Luan Y.; Liu J.; Gao J.; Wang J.; The design and synthesis of novel phenothiazine derivatives as potential cytotoxic agents. Lett Drug Des Discov  2019,17(1),57-67","journal-title":"Lett Drug Des Discov"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acsinfecdis.7b00157","volume":"4","author":"Montoya M.C.","year":"2018","unstructured":"Montoya M.C.; DiDone L.; Heier R.F.; Meyers M.J.; Krysan D.J.; Antifungal phenothiazines: Optimization, characterization of mechanism, and modulation of neuroreceptor activity. ACS Infect Dis  2018,4(4),499-507","journal-title":"ACS Infect Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"37568","DOI":"10.18632\/oncotarget.17247","volume":"8","author":"Oliva C.R.","year":"2017","unstructured":"Oliva C.R.; Zhang W.; Langford C.; Suto M.J.; Griguer C.E.; Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit. Oncotarget  2017,8(23),37568-37583","journal-title":"Oncotarget"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1295185","DOI":"10.3389\/fonc.2023.1295185","volume":"13","author":"Vanneste M.","year":"2023","unstructured":"Vanneste M.; Venzke A.; Guin S.; Fuller A.J.; Jezewski A.J.; Beattie S.R.; Krysan D.J.; Meyers M.J.; Henry M.D.; The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition. Front Oncol  2023,13,1295185","journal-title":"Front Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.dyepig.2016.09.015","volume":"136","author":"Wainwright M.","year":"2017","unstructured":"Wainwright M.; McLean A.; Rational design of phenothiazinium derivatives and photoantimicrobial drug discovery. Dyes Pigments  2017,136,590-600","journal-title":"Dyes Pigments"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/antibiotics13090834","volume":"13","author":"Lorente-Torres B.","year":"2024","unstructured":"Lorente-Torres B.; Llano-Verdeja J.; Casta\u00f1era P.; Ferrero H.\u00c1.; Fern\u00e1ndez-Mart\u00ednez S.; Javadimarand F.; Mateos L.M.; Letek M.; Mourenza \u00c1.; Innovative strategies in drug repurposing to tackle intracellular bacterial pathogens. Antibiotics  2024,13(9),834","journal-title":"Antibiotics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1134\/S1070363220030214","volume":"90","author":"Guguloth V.","year":"2020","unstructured":"Guguloth V.; Thirukovela N.S.; Paidakula S.; Vadde R.; One-pot regioselective synthesis of some novel isoxazole-phenothiazine hybrids and their antibacterial activity. Russ J Gen Chem  2020,90(3),470-475","journal-title":"Russ J Gen Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2174\/1568026622666220321124452","volume":"22","author":"Monteiro K.L.C.","year":"2022","unstructured":"Monteiro K.L.C.; Silva O.N.; dos Santos Nascimento I.J.; Mendon\u00e7a J\u00fanior F.J.B.; Aquino P.G.V.; da Silva-J\u00fanior E.F.; de Aquino T.M.; Medicinal chemistry of inhibitors targeting resistant bacteria. Curr Top Med Chem  2022,22(24),1983-2028","journal-title":"Curr Top Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.rechem.2024.101565","volume":"8","author":"Babalola B.A.","year":"2024","unstructured":"Babalola B.A.; Malik M.; Sharma L.; Olowokere O.; Folajimi O.; Exploring the therapeutic potential of phenothiazine derivatives in medicinal chemistry. Results Chem  2024,8,101565","journal-title":"Results Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.2174\/0109298673301266240506083014","volume":"32","author":"Nehra B.","year":"2025","unstructured":"Nehra B.; Kumar M.; Singh S.; Chawla V.; A Chawla P.; Grover P.; Recent developments in the antimicrobial potential of some nitrogenous heterocycles and their SAR studies: A review. Curr Med Chem  2025,32(41),9273-9323","journal-title":"Curr Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jhet.4586","volume":"60","author":"Pandhurnekar C.P.","year":"2023","unstructured":"Pandhurnekar C.P.; Pandhurnekar H.C.; Mungole A.J.; Butoliya S.S.; Yadao B.G.; A review of recent synthetic strategies and biological activities of isoxazole. J Heterocycl Chem  2023,60(4),537-565","journal-title":"J Heterocycl Chem"},{"key":"ref=43","first-page":"725","volume":"18","author":"Amaral L.","year":"2004","unstructured":"Amaral L.; Viveiros M.; Molnar J.; Antimicrobial activity of phenothiazines. In Vivo  2004,18(6),725-731","journal-title":"In Vivo"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1439-0507.2007.01371.x","volume":"50","author":"Vitale R.G.","year":"2007","unstructured":"Vitale R.G.; Afeltra J.; Meis J.F.G.M.; Verweij P.E.; Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes. Mycoses  2007,50(4),270-276","journal-title":"Mycoses"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13693780802378853","volume":"47","author":"Galg\u00f3czy L.","year":"2009","unstructured":"Galg\u00f3czy L.; Papp T.; Kov\u00e1cs L.; \u00d6rd\u00f6gh L.; V\u00e1gv\u00f6lgyi C.; In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis. Med Mycol  2009,47(3),331-335","journal-title":"Med Mycol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bmc.2004.09.059","volume":"13","author":"Darvesh S.","year":"2005","unstructured":"Darvesh S.; McDonald R.S.; Penwell A.; Conrad S.; Darvesh K.V.; Mataija D.; Gomez G.; Caines A.; Walsh R.; Martin E.; Structure\u2013activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorg Med Chem  2005,13(1),211-222","journal-title":"Bioorg Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/030006058000800409","volume":"8","author":"Aref M.A.","year":"1980","unstructured":"Aref M.A.; El-Guindy T.A.; Pipothiazine palmitate in the long-term treatment of schizophrenia. J Int Med Res  1980,8(4),293-294","journal-title":"J Int Med Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jscs.2011.02.003","volume":"16","author":"Raval J.P.","year":"2012","unstructured":"Raval J.P.; Desai K.G.; Desai K.R.; Microwave synthesis, characterization and antimicrobial study of new pyrazolyl-oxopropyl-quinazolin-4(3H)-one derivatives. J Saudi Chem Soc  2012,16(4),387-393","journal-title":"J Saudi Chem Soc"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejmech.2010.10.019","volume":"46","author":"Sarmiento G.P.","year":"2011","unstructured":"Sarmiento G.P.; Vitale R.G.; Afeltra J.; Moltrasio G.Y.; Moglioni A.G.; Synthesis and antifungal activity of some substituted phenothiazines and related compounds. Eur J Med Chem  2011,46(1),101-105","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2598062","volume":"2018","author":"Nyamu S.N.","year":"2018","unstructured":"Nyamu S.N.; Ombaka L.; Masika E.; Ng\u2019ang\u2019a M.; Antimicrobial photodynamic activity of phthalocyanine derivatives. Adv Chem  2018,2018(1),1-8","journal-title":"Adv Chem"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.25434\/BALESTRI-LORENZO-JACOPO-ILIC_PHD2022","author":"Balestri L.J.I.","year":"2022","unstructured":"Balestri L.J.I.;  Synthesis of antifungal compounds Doctor of Philosophy  2022","journal-title":"Synthesis of antifungal compounds Doctor of Philosophy"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"e02322","DOI":"10.1016\/j.heliyon.2019.e02322","volume":"5","author":"Manzur M.E.","year":"2019","unstructured":"Manzur M.E.; Brand\u00e1n, S.A. S(-) and R(+) species derived from antihistaminic promethazine agent: Structural and vibrational studies. Heliyon  2019,5(9),e02322","journal-title":"Heliyon"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/17460441.2018.1514386","volume":"13","author":"Blanco P.","year":"2018","unstructured":"Blanco P.; Sanz-Garc\u00eda F.; Hernando-Amado S.; Mart\u00ednez J.L.; Alcalde-Rico M.; The development of efflux pump inhibitors to treat Gram-negative infections. Expert Opin Drug Discov  2018,13(10),919-931","journal-title":"Expert Opin Drug Discov"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/AAC.02593-12","volume":"57","author":"Chamoun-Emanuelli A.M.","year":"2013","unstructured":"Chamoun-Emanuelli A.M.; Pecheur E.I.; Simeon R.L.; Huang D.; Cremer P.S.; Chen Z.; Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. Antimicrob Agents Chemother  2013,57(6),2571-2581","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"Dyall J.","year":"2014","unstructured":"Dyall J.; Coleman C.M.; Hart B.J.; Venkataraman T.; Holbrook M.R.; Kindrachuk J.; Johnson R.F.; Olinger G.G.; Jahrling P.B.; Laidlaw M.; Johansen L.M.; Lear-Rooney C.M.; Glass P.J.; Hensley L.E.; Frieman M.B.; Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother  2014,58(8),4885-4893","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/1099-1344(200008)43:9<865:AID-JLCR370>3.0.CO;2-E","volume":"43","author":"Kitamura K.","year":"2000","unstructured":"Kitamura K.; Fujitani K.; Takahashi K.; Tanaka Y.; Hirako S.; Kotani C.; Hashimoto T.; Takegami S.; Synthesis of [N-13CH3] drugs (chlorpromazine, triflupromazine and promazine). J Labelled Comp Radiopharm  2000,43(9),865-872","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","volume":"115","author":"Beignon A.S.","year":"2005","unstructured":"Beignon A.S.; McKenna K.; Skoberne M.; Manches O.; DaSilva I.; Kavanagh D.G.; Larsson M.; Gorelick R.J.; Lifson J.D.; Bhardwaj N.; Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor- viral RNA interactions. J Clin Invest  2005,115(11),3265-3275","journal-title":"J Clin Invest"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.virol.2010.02.015","volume":"401","author":"Bhattacharyya S.","year":"2010","unstructured":"Bhattacharyya S.; Warfield K.L.; Ruthel G.; Bavari S.; Aman M.J.; Hope T.J.; Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology  2010,401(1),18-28","journal-title":"Virology"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13567-020-0739-7","volume":"51","author":"Wei X.","year":"2020","unstructured":"Wei X.; She G.; Wu T.; Xue C.; Cao Y.; PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated endocytosis and traffics via the endo-\/lysosome pathway. Vet Res  2020,51(1),10","journal-title":"Vet Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0099-5428(08)60043-X","volume":"2","author":"Florey K.","year":"1973","unstructured":"Florey K.; Fluphenazine hydrochloride. Analytical Profiles of Drug Substances  1973,2,263-294","journal-title":"Analytical Profiles of Drug Substances"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","volume":"77","author":"Dyall J.","year":"2017","unstructured":"Dyall J.; Gross R.; Kindrachuk J.; Johnson R.F.; Olinger G.G.; Hensley L.E.; Frieman M.B.; Jahrling P.B.; Middle East respiratory syndrome and severe acute respiratory syndrome: Current therapeutic options and potential targets for novel therapies. Drugs  2017,77(18),1935-1966","journal-title":"Drugs"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","volume":"25","author":"Pillaiyar T.","year":"2020","unstructured":"Pillaiyar T.; Meenakshisundaram S.; Manickam M.; Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today  2020,25(4),668-688","journal-title":"Drug Discov Today"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1128\/AAC.03977-14","volume":"59","author":"Liu Q.","year":"2015","unstructured":"Liu Q.; Xia S.; Sun Z.; Wang Q.; Du L.; Lu L.; Jiang S.; Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry. Antimicrob Agents Chemother  2015,59(1),742-744","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"173553","DOI":"10.1016\/j.ejphar.2020.173553","volume":"887","author":"Otr\u0119ba M.","year":"2020","unstructured":"Otr\u0119ba M.; Ko\u015bmider L.; Rzepecka-Stojko A.; Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. Eur J Pharmacol  2020,887,173553","journal-title":"Eur J Pharmacol"},{"key":"ref=65","first-page":"77","volume":"12","author":"Bhatnagar A.","year":"2022","unstructured":"Bhatnagar A.; Pemawat G.; Recent developments of antipsychotic drugs with phenothiazine hybrids: A review. Chem Biol INTERFACE  2022,12(4),77-87","journal-title":"Chem Biol INTERFACE"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.antiviral.2018.08.013","volume":"158","author":"Lee N.","year":"2018","unstructured":"Lee N.; Shum D.; K\u00f6nig A.; Kim H.; Heo J.; Min S.; Lee J.; Ko Y.; Choi I.; Lee H.; Radu C.; Hoenen T.; Min J.Y.; Windisch M.P.; High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Antiviral Res  2018,158,226-237","journal-title":"Antiviral Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e28923","DOI":"10.1371\/journal.pone.0028923","volume":"6","author":"Pohjala L.","year":"2011","unstructured":"Pohjala L.; Utt A.; Varjak M.; Lulla A.; Merits A.; Ahola T.; Tammela P.; Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One  2011,6(12),e28923","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e15483","DOI":"10.1371\/journal.pone.0015483","volume":"5","author":"Filone C.M.","year":"2010","unstructured":"Filone C.M.; Hanna S.L.; Caino M.C.; Bambina S.; Doms R.W.; Cherry S.; Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon. PLoS One  2010,5(11),e15483","journal-title":"PLoS One"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"105481","DOI":"10.1016\/j.antiviral.2022.105481","volume":"209","author":"Hashizume M.","year":"2023","unstructured":"Hashizume M.; Takashima A.; Ono C.; Okamoto T.; Iwasaki M.; Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1. Antiviral Res  2023,209,105481","journal-title":"Antiviral Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/v15081666","volume":"15","author":"Liang T.","year":"2023","unstructured":"Liang T.; Xiao S.; Wu Z.; Lv X.; Liu S.; Hu M.; Li G.; Li P.; Ma X.; Phenothiazines inhibit SARS-CoV-2 entry through targeting spike protein. Viruses  2023,15(8),1666","journal-title":"Viruses"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.21873\/anticanres.12045","volume":"37","author":"Varga B.","year":"2017","unstructured":"Varga B.; Csonka \u00c1.; Csonka A.; Moln\u00e1r J.; Amaral L.; Spengler G.; Possible biological and clinical applications of phenothiazines. Anticancer Res  2017,37(11),5983-5993","journal-title":"Anticancer Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"241628","DOI":"10.1098\/rsos.241628","volume":"12","author":"Singh S.","year":"2025","unstructured":"Singh S.; Gangopadhyay A.; D S.; Chakravarty M.; Phenothiazine-linked glutamic acid dendrons: An easy access and a new class of SARS-CoV-2 main protease inhibitors. R Soc Open Sci  2025,12(4),241628","journal-title":"R Soc Open Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.antiviral.2007.12.005","volume":"79","author":"Barnard D.L.","year":"2008","unstructured":"Barnard D.L.; Day C.W.; Bailey K.; Heiner M.; Montgomery R.; Lauridsen L.; Jung K.H.; Li J.K.K.; Chan P.K.S.; Sidwell R.W.; Is the anti-psychotic, 10-(3-(dimethylamino)propyl) phenothiazine (promazine), a potential drug with which to treat SARS infections? Antiviral Res  2008,79(2),105-113","journal-title":"Antiviral Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"106274","DOI":"10.1016\/j.ijantimicag.2020.106274","volume":"57","author":"Plaze M.","year":"2021","unstructured":"Plaze M.; Attali D.; Prot M.; Petit A.C.; Blatzer M.; Vinckier F.; Levillayer L.; Chiaravalli J.; Perin-Dureau F.; Cachia A.; Friedlander G.; Chr\u00e9tien F.; Simon-Loriere E.; Gaillard R.; Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. Int J Antimicrob Agents  2021,57(3),106274","journal-title":"Int J Antimicrob Agents"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1139\/cjc-2021-0139","volume":"99","author":"Forrestall K.L.","year":"2021","unstructured":"Forrestall K.L.; Burley D.E.; Cash M.K.; Pottie I.R.; Darvesh S.; Forrestall K.L.; Burley D.E.; Cash M.K.; Pottie I.R.; Darvesh S.; Phenothiazines as dual inhibitors of SARS-CoV-2 main protease and COVID-19 inflammation. Can J Chem  2021,99(10),801-811","journal-title":"Can J Chem"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.11.557219","author":"Forrestall K.","year":"2023","unstructured":"Forrestall K.; Pringle E.S.; Sands D.; Duguay B.A.; Farewell B.; Woldemariam T.; Falzarano D.; Pottie I.; Mccormick C.; Dual inhibition of Coronavirus Mpro and PLpro enzymes by phenothiazines and their antiviral activity. Biorxiv  2023","journal-title":"Biorxiv"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1007\/s11033-022-07594-9","volume":"49","author":"Saklani P.","year":"2022","unstructured":"Saklani P.; Khan H.; Singh T.G.; Gupta S.; Grewal A.K.; Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: A proposed mechanistic insight. Mol Biol Rep  2022,49(10),10101-10113","journal-title":"Mol Biol Rep"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","volume":"279","author":"Aggarwal M.","year":"2024","unstructured":"Aggarwal M.; Patra A.; Awasthi I.; George A.; Gagneja S.; Gupta V.; Capalash N.; Sharma P.; Drug repurposing against antibiotic resistant bacterial pathogens. Eur J Med Chem  2024,279,116833","journal-title":"Eur J Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"106307","DOI":"10.1016\/j.micpath.2023.106307","volume":"183","author":"Mathur A.","year":"2023","unstructured":"Mathur A.; Parihar A.S.; Modi S.; Kalra A.; Photodynamic therapy for ESKAPE pathogens: An emerging approach to combat antimicrobial resistance (AMR). Microb Pathog  2023,183,106307","journal-title":"Microb Pathog"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2174\/138945006778226660","volume":"7","author":"Tsakovska I.","year":"2006","unstructured":"Tsakovska I.; Pajeva I.; Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance. Curr Drug Targets  2006,7(9),1123-1134","journal-title":"Curr Drug Targets"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s42003-022-03172-8","volume":"5","author":"Mohiuddin S.G.","year":"2022","unstructured":"Mohiuddin S.G.; Nguyen T.V.; Orman M.A.; Pleiotropic actions of phenothiazine drugs are detrimental to gram-negative bacterial persister cells. Commun Biol  2022,5(1),217","journal-title":"Commun Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1573394713666170524122904","volume":"13","author":"Mishra R.","year":"2017","unstructured":"Mishra R.; Sareen S.; Sharma B.; Goyal S.; Kaur G.; Bhardwaj S.; Siddiqui A.A.; Husain A.; Singla R.K.; Rashid M.; Kumar D.; Sati B.; Shalmali N.; Kumar R.; Phenothiazines and related drugs as multi drug resistance reversal agents in cancer chemotherapy mediated by p-glycoprotein. Curr Cancer Ther Rev  2017,13(1),28-42","journal-title":"Curr Cancer Ther Rev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1021\/jm010549o","volume":"45","author":"Guan J.","year":"2002","unstructured":"Guan J.; Kyle D.E.; Gerena L.; Zhang Q.; Milhous W.K.; Lin A.J.; Design, synthesis, and evaluation of new chemosensitizers in multi-drug-resistant Plasmodium falciparum. J Med Chem  2002,45(13),2741-2748","journal-title":"J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1016\/j.bmc.2008.05.040","volume":"16","author":"Bisi A.","year":"2008","unstructured":"Bisi A.; Meli M.; Gobbi S.; Rampa A.; Tolomeo M.; Dusonchet L.; Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives. Bioorg Med Chem  2008,16(13),6474-6482","journal-title":"Bioorg Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1734-1140(13)71060-0","volume":"65","author":"Laso\u0144 W.","year":"2013","unstructured":"Laso\u0144 W.; Chlebicka M.; Rejdak K.; Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacol Rep  2013,65(4),787-801","journal-title":"Pharmacol Rep"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3998\/ark.5550190.0009.223","author":"Trivedi A.R.","year":"2008","unstructured":"Trivedi A.R.; Siddiqui A.B.; Shah V.H.; Design, synthesis, characterization and antitubercular activity of some 2-heterocycle-substituted phenothiazines. ARKIVOC  2008(2),210-217","journal-title":"ARKIVOC"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1155\/2009\/901646","volume":"6","author":"Upadhyay R.K.","year":"2009","unstructured":"Upadhyay R.K.; Upadhyay M.S.; Jain S.; Synthesis and antimicrobial activity of 1-[2-(10-p-chlorobenzyl) phenothiazinyl]-3-(substituted aryl)-2-propen-1-ones. J Chem  2009,6(Suppl. 1),S254-S258","journal-title":"J Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.9734\/bpi\/cacb\/v4\/1783F","author":"Dighe N.S.","year":"2021","unstructured":"Dighe N.S.; Bankar A.A.; Musmade D.S.; Nirmal S.A.; Research on synthesis and anti convulsant activity of novel oxadiazole substituted phenothiazine derivatives. Curr Adv Chem Biochem  2021(4),54-60","journal-title":"Curr Adv Chem Biochem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41392-023-01344-4","volume":"8","author":"Wang J.","year":"2023","unstructured":"Wang J.; Zhou Y.; Zhang H.; Hu L.; Liu J.; Wang L.; Wang T.; Zhang H.; Cong L.; Wang Q.; Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther  2023,8(1),138","journal-title":"Signal Transduct Target Ther"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphar.2019.00294","volume":"10","author":"Watts A.M.","year":"2019","unstructured":"Watts A.M.; Cripps A.W.; West N.P.; Cox A.J.; Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol  2019,10(MAR),294","journal-title":"Front Pharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1515\/afmnai-2015-0001","volume":"32","author":"Stojkovi\u0107 N.","year":"2015","unstructured":"Stojkovi\u0107 N.; Ceki\u0107 S.; Ristov M.; Risti\u0107 M.; \u0110uki\u0107 D.; Bini\u0107 M.; Virijevi\u0107 D.; Histamine and Antihistamines \/ Histamin i antihistamini. Sci J Fac Med Ni\u0161  2015,32(1),7-22","journal-title":"Sci J Fac Med Ni\u0161"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/S0968-0896(00)00126-7","volume":"8","author":"Tobe M.","year":"2000","unstructured":"Tobe M.; Isobe Y.; Goto Y.; Obara F.; Tsuchiya M.; Matsui J.; Hirota K.; Hayashi H.; Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction. Bioorg Med Chem  2000,8(8),2037-2047","journal-title":"Bioorg Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/antiox9090842","volume":"9","author":"Nishikawa S.","year":"2020","unstructured":"Nishikawa S.; Inoue Y.; Hori Y.; Miyajima C.; Morishita D.; Ohoka N.; Hida S.; Makino T.; Hayashi H.; Anti-inflammatory activity of kurarinone involves induction of HO-1 via the KEAP1\/Nrf2 pathway. Antioxidants  2020,9(9),842","journal-title":"Antioxidants"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.bmcl.2009.03.124","volume":"19","author":"Kubota K.","year":"2009","unstructured":"Kubota K.; Kurebayashi H.; Miyachi H.; Tobe M.; Onishi M.; Isobe Y.; Synthesis and structure\u2013activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H1 antagonists. Bioorg Med Chem Lett  2009,19(10),2766-2771","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-4-431-68263-9_9","author":"Tasaka K.","year":"1994","unstructured":"Tasaka K.;  New Advances in Histamine Research  1994,293-324","journal-title":"New Advances in Histamine Research"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"365","DOI":"10.17628\/ecb.2017.6.365-375","volume":"6","author":"Atta E.M.","year":"2017","unstructured":"Atta E.M.; Mohamed N.H.; Abdelgawad A.A.M.; Antioxidants: An overview on the natural and synthetic types. Eur Chem Bull  2017,6(8),365","journal-title":"Eur Chem Bull"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejmech.2019.07.043","volume":"180","author":"Pathania S.","year":"2019","unstructured":"Pathania S.; Narang R.K.; Rawal R.K.; Role of sulphur-heterocycles in medicinal chemistry: An update. Eur J Med Chem  2019,180,486-508","journal-title":"Eur J Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.4067\/S0717-97072015000200012","volume":"60","author":"Maddila S.","year":"2015","unstructured":"Maddila S.; Momin M.; Gorle S.; Palakondu L.; Jonnalagadda S.B.; Synthesis and antioxidant evaluation of novel phenothiazine linked substitutedbenzylideneamino-1,2,4-triazole derivatives. J Chil Chem Soc  2015,60(2),2919-2923","journal-title":"J Chil Chem Soc"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.3390\/molecules25194566","volume":"25","author":"Al Zahrani N.A.","year":"2020","unstructured":"Al Zahrani N.A.; El-Shishtawy R.M.; Elaasser M.M.; Asiri A.M.; Synthesis of novel chalcone-based phenothiazine derivatives as antioxidant and anticancer agents. Molecules  2020,25(19),4566","journal-title":"Molecules"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/jhet.2716","volume":"54","author":"Hamama W.S.","year":"2017","unstructured":"Hamama W.S.; Gouda M.A.; Kamal El-din, H.A.; Zoorob, H.H. Synthesis and antioxidant activity of some new binary pyrazoles containing core phenothiazine moiety. J Heterocycl Chem  2017,54(2),1369-1377","journal-title":"J Heterocycl Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1039\/b009171p","volume":"127","author":"Antolovich M.","year":"2002","unstructured":"Antolovich M.; Prenzler P.D.; Patsalides E.; McDonald S.; Robards K.; Methods for testing antioxidant activity. Analyst  2002,127(1),183-198","journal-title":"Analyst"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semcancer.2020.03.011","volume":"68","author":"Kaushik I.","year":"2021","unstructured":"Kaushik I.; Ramachandran S.; Prasad S.; Srivastava S.K.; Drug rechanneling: A novel paradigm for cancer treatment. Semin Cancer Biol  2021,68,279-290","journal-title":"Semin Cancer Biol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1134\/S2079978019020018","volume":"9","author":"Gopi C.","year":"2019","unstructured":"Gopi C.; Dhanaraju M.D.; Recent progress in synthesis, structure and biological activities of phenothiazine derivatives. Rev J Chem  2019,9(2),95-126","journal-title":"Rev J Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/ph16071050","volume":"16","author":"Raslan M.A.","year":"2023","unstructured":"Raslan M.A.; Raslan S.A.; Shehata E.M.; Mahmoud A.S.; Sabri N.A.; Advances in the applications of bioinformatics and chemoinformatics. Pharmaceuticals  2023,16(7),1050","journal-title":"Pharmaceuticals"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jat.4046","volume":"41","author":"Otr\u0119ba M.","year":"2021","unstructured":"Otr\u0119ba M.; Ko\u015bmider L.; In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review. J Appl Toxicol  2021,41(1),82-94","journal-title":"J Appl Toxicol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/7081_2007_108","volume":"15","author":"Dasgupta A.","year":"2008","unstructured":"Dasgupta A.; Dastidar S.G.; Shirataki Y.; Motohashi N.; Antibacterial activity of artificial phenothiazines and isoflavones from plants. Top Heterocycl Chem  2008,15,67-132","journal-title":"Top Heterocycl Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jps.2600590712","volume":"59","author":"Huang C.L.","year":"1970","unstructured":"Huang C.L.; Mir G.M.; Yeh J.Z.; Distribution, excretion, and metabolism of 14C-labeled quaternary ammonium salt of perphenazine in rats. J Pharm Sci  1970,59(7),976-979","journal-title":"J Pharm Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4236\/ijcm.2012.35067","volume":"3","author":"Lange I.E.S.","year":"2012","unstructured":"Lange I.E.S.; Pral E.M.F.; Magdaleno A.; Silber A.M.; Evaluation of the anti-trypanosoma cruzi effects of the antipsychotic drug Levomepromazine. Int J Clin Med  2012,3(5),344-351","journal-title":"Int J Clin Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1183\/09031936.00113713","volume":"43","author":"Alsaad N.","year":"2014","unstructured":"Alsaad N.; Wilffert B.; van Altena R.; de Lange W.C.M.; van der Werf T.S.; Kosterink J.G.W.; Alffenaar J.W.C.; Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis. Eur Respir J  2014,43(3),884-897","journal-title":"Eur Respir J"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14232\/abs.2019.2.181-184","volume":"63","author":"Szerencs\u00e9s B.","year":"2019","unstructured":"Szerencs\u00e9s B.; M\u00fclbacher A.; V\u00e1gv\u00f6lgyi C.; Pfeiffer I.; Acta biologica szegediensis. Acta Biol Szeged  2019,63(2),181-184","journal-title":"Acta Biol Szeged"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.micres.2004.10.002","volume":"160","author":"Rani Basu L.","year":"2005","unstructured":"Rani Basu L.; Mazumdar K.; Kumar Dutta N.; Karak P.; Dastidar S.G.; Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine. Microbiol Res  2005,160(1),95-100","journal-title":"Microbiol Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bmcl.2016.03.056","volume":"26","author":"Kushwaha K.","year":"2016","unstructured":"Kushwaha K.; Kaushik N.K.; Kaushik N.; Chand M.; Kaushik R.; Choi E.; Jain S.C.; Novel aminoalkylated azaphenothiazines as potential inhibitors of T98G, H460 and SNU80 cancer cell lines in vitro. Bioorg Med Chem Lett  2016,26(9),2237-2244","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1055\/a-1323-2813","volume":"71","author":"Jain A.","year":"2021","unstructured":"Jain A.; Chaudhary J.; Khaira H.; Chopra B.; Dhingra A.; Piperazine: A promising scaffold with analgesic and anti-inflammatory potential. Drug Res  2021,71(2),62-72","journal-title":"Drug Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2174\/1567201815666180830100015","volume":"15","author":"Raikar P.","year":"2018","unstructured":"Raikar P.; Gurupadayya B.; Koganti V.S.; Recent Advances in chiral separation of antihistamine drugs: Analytical and bioanalytical methods. Curr Drug Deliv  2018,15(10),1393-1410","journal-title":"Curr Drug Deliv"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1080\/14756366.2019.1639695","volume":"34","author":"Morak-M\u0142odawska B.","year":"2019","unstructured":"Morak-M\u0142odawska B.; Pluta K.; Latocha M.; Jele\u0144 M.; Ku\u015bmierz D.; Suwi\u0144ska K.; Shkurenko A.; Czuba Z.; Jurzak M.; 10 H -1,9-diazaphenothiazine and its 10-derivatives: Synthesis, characterisation and biological evaluation as potential anticancer agents. J Enzyme Inhib Med Chem  2019,34(1),1298-1306","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000135884","volume":"15","author":"Trnavsk\u00fd K.","year":"1966","unstructured":"Trnavsk\u00fd K.; Kopeck\u00fd \u0160.; The influence of some anti-inflammatory drugs on the inflammatory reaction to Sodium Urate. Pharmacology  1966,15(3),322-327","journal-title":"Pharmacology"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-2999(85)90235-3","volume":"112","author":"Schaller-Clostre F.","year":"1985","unstructured":"Schaller-Clostre F.; Dunant Y.; Antipsychotic drugs depress acetylcholine release in the Torpedo electric organ, a purely cholinergic system. Eur J Pharmacol  1985,112(1),27-37","journal-title":"Eur J Pharmacol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/082585971302900307","volume":"29","author":"Hohl C.M.","year":"2013","unstructured":"Hohl C.M.; Stenekes S.; Harlos M.S.; Shepherd E.; McClement S.; Chochinov H.M.; Methotrimeprazine for the management of end-of-life symptoms in infants and children. J Palliat Care  2013,29(3),178-185","journal-title":"J Palliat Care"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4236\/pp.2015.68042","volume":"6","author":"D\u00e9sam\u00e9ricq G.","year":"2015","unstructured":"D\u00e9sam\u00e9ricq G.; Sch\u00fcrhoff F.; Macquin-Mavier I.; Bachoud-L\u00e9vi A.C.; Maison P.; Use of antipsychotics: A study from the French national insurance healthcare system database. Pharmacol Pharm  2015,6(8),411-419","journal-title":"Pharmacol Pharm"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575400761251007165058","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/246997\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575400761251007165058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:38:54Z","timestamp":1781973534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/246997\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575400761251007165058","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}